Parameter
| Biomarker | ST3GAL5 | Full name | ST3 Beta-Galactoside Alpha-2,3-Sialyltransferase 5 | Molecular Type | Protein (enzyme) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis & therapeutic target |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Tissue (detection platform not specified) | ||
| Pathobiological Mechanisms | Down-regulated in BC; low expression associated with muscle invasion, high grade & poor prognosis; tumor-suppressive function | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | Sialyl-transferase with anti-cancer activity; prognostic & therapeutic potential | ||||